Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DARIFENACIN HYDROBROMIDE vs DAROLUTAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DARIFENACIN HYDROBROMIDE vs DAROLUTAMIDE: Safety Overview

Metric DARIFENACIN HYDROBROMIDE DAROLUTAMIDE
Total FAERS Reports 193 3,247
Deaths Reported 65 508
Death Rate 33.7% 15.6%
Hospitalizations 43 723
Average Patient Age 74.5 yrs 73.6 yrs
% Female Patients 80.5% 0.4%
FDA Approval Date Dec 22, 2004 Jul 30, 2019
Manufacturer Cipla USA Inc. Bayer HealthCare Pharmaceuticals Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription